No. 25A519
Bristol Myers Squibb Company v. Robert F. Kennedy, Secretary of Health and Human Services, et al.
Tags: constitutional-challenge drug-pricing fifth-amendment first-amendment inflation-reduction-act medicare-drug-negotiation
Latest Conference:
N/A
Question Presented (from Petition)
Question not identified.
Question Presented (AI Summary)
Whether the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act of 2022 violates the Fifth and First Amendments
Docket Entries
2025-11-06
Application (25A519) granted by Justice Alito extending the time to file until December 19, 2025.
2025-11-03
Application (25A519) to extend the time to file a petition for a writ of certiorari from December 3, 2025 to December 19, 2025, submitted to Justice Alito.
Attorneys
Bristol Myers Squibb Company
Noel John Francisco — Jones Day, Petitioner
Robert F. Kennedy, Jr., Secretary of Health and Human Services, et al.
D. John Sauer — Solicitor General, Respondent